Clinical trial
Proenkephalin ANd Creatinine in the Prediction of Cardiac Contrast-Associated Kidney Events
NCT03989505 is registered in ClinicalTrials.gov with Dr. med. Mahir Karakas as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Proenkephalin ANd Creatinine in the Prediction of Cardiac Contrast-Associated Kidney Events
- Lead sponsor
- Dr. med. Mahir Karakas
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 1, 2018
- Completion date
- December 31, 2021
- Enrollment
- 220 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute kidney injury, contrast-induced nephropathy, coronary artery disease